AstraZeneca strikes deal for up to US$18.5 billion to license weight-loss drugs from China's CSPC
The deal builds on existing collaboration between the companies in areas such as artificial intelligence AstraZeneca will license…
Tag
The deal builds on existing collaboration between the companies in areas such as artificial intelligence AstraZeneca will license…
The Trump administration has reached a deal with pharmaceutical giant AstraZeneca to cut its drug prices, marking it the second drugmaker…
Mitchell LabiakBusiness reporter and Simon JackBusiness editor AstraZeneca has paused plans to invest £200m at a Cambridge research site…
British pharmaceutical giant AstraZeneca on Tuesday (Jul 29) said net profit rose 27 per cent in the second quarter, boosted by record…
AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030, it said on Monday, the…
[MUNICH/WASHINGTON] AstraZeneca plans to invest US$50 billion in the US before 2030, becoming the latest European pharma company to…
Ever since AstraZeneca shocked investors in October with news its China chief was under investigation, the British pharmaceutical giant…
AstraZeneca will invest US$2.5 billion in a new research centre in Beijing, in a major show of commitment to China just months after the…
BRITISH pharmaceutical giant AstraZeneca said on Friday (Jan 31) that it was abandoning plans to build a £450 million (S$756.9 million)…
BEIJING’S mayor called on AstraZeneca to expand its research and development investment in the Chinese capital, signalling that a probe…
DRUGMAKER AstraZeneca lifted its annual sales and profit forecast for the second time in less than four months on Tuesday (Nov 12), helped…